Company Analysis DermTech, Inc.
1. Summary
Advantages
- Price (0.6249 $) is less than fair price (0.9867 $)
Disadvantages
- Dividends (0%) are below the sector average (0.5442%).
- The stock's return over the last year (-98.06%) is lower than the sector average (-15.96%).
- Current debt level 44.61% has increased over 5 years from 0%.
- The company's current efficiency (ROE=-176.45%) is lower than the sector average (ROE=9.61%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| DermTech, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -16.8% | 0.9% |
| 90 days | 0% | -20.8% | 6.4% |
| 1 year | -98.1% | -16% | 32.2% |
DMTK vs Sector: DermTech, Inc. has significantly underperformed the "Healthcare" sector by -82.1% over the past year.
DMTK vs Market: DermTech, Inc. has significantly underperformed the market by -130.21% over the past year.
Stable price: DMTK is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: DMTK with weekly volatility of -1.89% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.6249 $) is lower than the fair price (0.9867 $).
Price significantly below the fair price: The current price (0.6249 $) is 57.9% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (58.85) is higher than that of the sector as a whole (48.77).
P/E vs Market: The company's P/E (58.85) is higher than that of the market as a whole (48.79).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.8963) is lower than that of the sector as a whole (4.82).
P/BV vs Market: The company's P/BV (0.8963) is lower than that of the market as a whole (3.36).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.35) is lower than that of the sector as a whole (33.76).
P/S vs Market: The company's P/S indicator (3.35) is lower than that of the market as a whole (10.23).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-0.7038) is higher than that of the sector as a whole (-22.15).
EV/Ebitda vs Market: The company's EV/Ebitda (-0.7038) is lower than that of the market as a whole (28.28).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 38.15% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (38.15%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (123.79%).
5.4. ROE
ROE vs Sector: The company's ROE (-176.45%) is lower than that of the sector as a whole (9.61%).
ROE vs Market: The company's ROE (-176.45%) is lower than that of the market as a whole (10.82%).
5.5. ROA
ROA vs Sector: The company's ROA (-82.74%) is lower than that of the sector as a whole (0.3443%).
ROA vs Market: The company's ROA (-82.74%) is lower than that of the market as a whole (6.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-38.67%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (-38.67%) is lower than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5442%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 11.12.2023 | Ibarra Claudia Chief Operating Officer |
Sale | 1.45 | 480 | 331 |
| 11.12.2023 | Sun Kevin M Chief Financial Officer |
Sale | 1.45 | 648 | 447 |
| 08.12.2023 | Ibarra Claudia Chief Operating Officer |
Sale | 1.41 | 3 676 | 2 607 |
| 07.12.2023 | Akhavan Ramin General Counsel |
Sale | 1.53 | 5 765 | 3 768 |
| 07.12.2023 | Ibarra Claudia Chief Operating Officer |
Sale | 1.53 | 5 984 | 3 911 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
